« Previous
Next »
Titles
- COVID-19 antivirals utilization: geographic and demographic patterns of treatment in 20221
- COVID-19 public health emergency: general considerations for pre-IND meeting requests for COVID-19 related drugs and biological products : guidance for industry and investigators1
- COVID-19: developing drugs and biological products for treatment or prevention1
- COVID-19: master protocols evaluating drugs and biological products for treatment or prevention1
- COVID-19: potency assay considerations for monoclonal antibodies and other therapeutic proteins targeting SARS-CoV-2 infectivity1
